Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-20 · accession 0001628280-24-024782 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-22 | 2024-05-20 | LFCR | Josephs Paul | CEO, Dir | A - Grant | — | +525.0K | 525.0K | New | — |
| D | 2024-05-22 | 2024-05-20 | LFCR | Josephs Paul | CEO, Dir | F - Tax | — | -8,975 | 516.0K | -2% | — |
| D | 2024-05-22 | 2024-05-20 | LFCR | Josephs Paul | CEO, Dir | A - Grant | $0.00 | +1.50M | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-20 | A | A | 525,000 | — | 525,000 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Common | Common Stock | 2024-05-20 | F | D | 8,975 | — | 516,025 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 3 | Derivative | Performance-Based Restricted Stock Units | 2024-05-20 | A | A | 1,500,000 | $0.00 | 0 | D | — · — to 2029-05-20 | 1,500,000 Common Stock | (F3) Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones. (F2) Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The performance-based restricted stock units vest, if it all, based on the Issuer's achievement of certain stock prices. |